TrialStem cell research & therapy2024

Bone marrow mesenchymal stem cell and mononuclear cell combination therapy in patients with type 2 diabetes mellitus: a randomized controlled study with 8-year follow-up.

Zhixian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.